APIcells

What APIcells does

APIcells is a private life-sciences distributor headquartered in Maussane, France with operational offices in Lowell, Massachusetts (M2D2, Wannalancit Mills Complex, 600 Suffolk Street) for North American distribution and a production facility in Mons, Belgium. The company serves as the contracted North American distribution partner of Ipracell (the producer), based on more than 20 years of Ipracell's cell-culture expertise. Its core offering is a catalog of mammalian cell biologicals — whole cell pellets, nuclear extracts (dialysed and non-dialysed), cytoplasmic extracts, S100 extracts, isolated nuclei, and mitochondria — derived from validated human and primate cell lines including HeLa, CV-1, K562, Jurkat, HL-60, L363, BV173, THP-1, U937, RAMOS, MOLT-4, and HUT-78.

Production is concentrated at the Ipracell facility in Mons, Belgium under GLP conditions, using sonoperfused fedbatch (cytostat) mode at a constant 5×10^6 cells/ml with cell viability maintained at 93–99%. HeLa nuclear extracts are prepared according to the Dignam, Lebovitz, and Roeder (1983) protocol with final protein concentration of approximately 6 mg/ml (Bradford). Quality control screening covers bacteria, yeast, fungi, and mycoplasma, with New Zealand-origin NBCS in the culture medium and harvest strictly from exponential-phase cells (>95% viability).

The business model is direct B2B e-commerce: research-grade mammalian cell products are listed on apicells.com at unit prices ranging from approximately $1,120 to $3,680, sold on a pay-as-you-go basis with volume-based size options. US orders ship immediately from stock in Lowell; HeLa products are shipped worldwide every Monday. Target customers are academic research institutions, public and private research groups, and biotechnology/pharmaceutical R&D entities that need reproducible subcellular fractions and extracts for SDS-PAGE, Gel Shift, HDAC, Western Blot, in vitro splicing, transcription factor, chromatin, ribosome, and mitochondrial studies. A custom-specific cell product service extends the offering to non-catalog needs.

Name

APIcells

Website

https://apicells.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

APIcells is a private life-sciences distributor serving as the North American distribution partner of Ipracell, selling mammalian cell biologicals — cell pellets, nuclear extracts, cytoplasmic extracts, nuclei, and mitochondria — to academic, public, and private research groups via direct e-commerce from US and Belgium stock.

Ownership category

akta.pro rank

Product category

Cell Biology Reagents

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI)

Keywords

• Mammalian cell products
• Nuclear extracts
• Cell biology reagents
• Subcellular fractions
• Research biologicals

Headquarters

HQ city

Maussane

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel

Revenue model

1. Cell Products Sales: One-time purchase of mammalian cell products including cell pellets, nuclear extracts, cytoplasm extracts, mitochondria, nuclei from various cell lines (HeLa, CV-1, K562, Jurkat, HL-60, L363, BV173, THP-1, U937, RAMOS, MOLT-4, HUT-78). Products sold in different sizes with per-unit pricing.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

APIcells produces and distributes mammalian cell-based biological reagents for academic and private research laboratories, including whole cell pellets, nuclear extracts (dialysed and non-dialysed), cytoplasmic extracts, S100 extracts, isolated nuclei, and mitochondria derived from validated cell lines such as HeLa, CV-1, K562, Jurkat, HL-60, L363, BV173, MOLT-4, RAMOS, U937, THP-1, and HUT-78. The company serves as the North American distribution arm of Ipracell, with products manufactured under GLP conditions in Mons, Belgium and shipped from US stock or directly worldwide for HeLa offerings.

Product overview

APIcells is a biotechnology company specializing in the production and distribution of mammalian cell products for academic, public, and private research institutions. The company offers a comprehensive portfolio of subcellular fractions and whole cell pellets derived from various mammalian cell lines including HeLa, CV-1, K562, Jurkat, MOLT-4, RAMOS, HL-60, BV173, L363, U937, THP-1, and HUT-78. Product categories include: Cell Pellets (whole cells for various applications including gDNA/RNA isolation, fixation, and lysate production); Nuclear Extracts (dialysed and non-dialysed versions containing transcription factors, chromatin proteins, and histones); Cytoplasmic Extracts and S100 extracts (containing ribosomal subunits, translation factors, and mRNA regulatory proteins); Nuclei (for nucleic acid research and protein expression studies); and Mitochondria (for mitochondrial process studies and protein/DNA purification). All products are manufactured under GLP conditions at the facility in Mons, Belgium, and distributed in North America through the Ipracell partnership.

Differentiator

Problem solved

Functional benefit

Products and services

• HeLa Cell Pellets

Quantifiable outcome

• Cell viability maintained at 93%-99% during production
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• IpracellcoreChannel Partner/ Reseller/ DistributorAPIcells is the distribution partner of Ipracell for North America. Ipracell, based on more than 20 years of expertise, operates a cell culture production facility in Mons, Belgium offering high quality biologicals at competitive prices. APIcells distributes Ipracell's mammalian cell products (cell pellets, lysates, nuclear extracts, cytoplasm/S100 extracts) from HeLa cell lines to the North American market, with immediate stock availability and shipping within the United States.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Cell Biolabs: Cell Biolabs manufactures cell-based assay kits, viral entry solutions, and cell biology reagents. It overlaps with APIcells in serving cell biology research labs with specialized, non-commodity biological products.
• iXCells Biotechnologies: iXCells provides primary cells, iPSC-derived cells, and cell-based services for drug discovery and research. It is closely comparable as a niche cell products and services provider targeting similar academic and pharma research customers.
• ATCC (American Type Culture Collection): ATCC is the gold-standard global supplier of authenticated cell lines, biological products, and subcellular reagents for research. It is the most direct competitor to APIcells, offering a much broader catalog but with longer lead times and less specialization in subcellular fractions.

Broad incumbents

• Lonza Bioscience: Lonza offers mammalian cell products, custom cell production services, and bioprocessing reagents. It competes with APIcells both as a direct cell products supplier and as a custom production alternative for research and industrial customers.
• Corning Life Sciences: Corning supplies cell culture vessels, media, and mammalian cell products under its Cellgro and Discovery Labware brands. It overlaps with APIcells in cell biology research consumables but at much greater scale and via institutional channels.
• Millipore Sigma (Sigma-Aldrich): MilliporeSigma supplies mammalian cell lines, nuclear extracts, and cell biology reagents as part of its broader life science catalog. Its scale, certifications, and global logistics make it a default vendor for the same academic and private research buyers APIcells targets.
• Thermo Fisher Scientific (Cell Biology Reagents): Thermo Fisher offers an extensive portfolio of cell biology research reagents, including cell lines, extracts, and subcellular fractions, through its Gibco and Invitrogen brands. It competes with APIcells on catalog breadth and institutional procurement rather than niche subcellular specialization.

Emerging players

• Neuromics: Neuromics supplies primary cells, cell lines, and cell biology reagents focused on neuroscience and stem cell applications. It is a smaller, emerging specialty supplier that competes with APIcells for share of academic research budgets in cell biology.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/apicells-inc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about APIcells